Influence of Hemoglobin Level on Muscle and Physical Functions, Activities of Daily Living, and Quality of Life in Patients With Hematological Malignancies

Integrative Cancer Therapies

Volumn 18, Issue , 2019, Pages

  Fukushima, Takuya ^a,b   Nakano, Jiro ^a   Ishii, Shun ^b   Natsuzako, Ayumi ^b   Kawachi, Haruna ^c   Sakamoto, Junya ^a   Miyazaki, Yasushi ^a   Okita, Minoru ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c Saga Ken Medical Centre Koseikan   (Japan)

Author keywords

anemia; hematologic malignancy; hemoglobin level; muscle function; physical function

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN;

AGED; ANXIETY; ARTICLE; CANCER PATIENT; CHEMORADIOTHERAPY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISTRESS SYNDROME; DYSPNEA; EVALUATION STUDY; FATIGUE; FEMALE; GRIP STRENGTH; HAND GRIP; HEMATOLOGIC MALIGNANCY; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; OBSERVATIONAL STUDY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SKELETAL MUSCLE; EXERCISE; HAND STRENGTH; HEMATOLOGIC DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACTIVITIES OF DAILY LIVING; AGED; CROSS-SECTIONAL STUDIES; DYSPNEA; EXERCISE; FATIGUE; FEMALE; HAND STRENGTH; HEMATOLOGIC NEOPLASMS; HEMOGLOBINS; HUMANS; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; QUALITY OF LIFE;

EID: 85064013122     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735419842196     Document Type: Article

References (55)

1. National Cancer Center. Monitoring of Cancer Incidence in Japan—Survival 2006-2008. Tokyo, Japan: Report Center for Cancer Control and Information Services, National Cancer Center; 2016.
2. Matsuda T, Ajiki W, Marugame T,; Research Group of Population-Based Cancer Registries of Japan. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol. 2011;41:40-51.
3. Ferlay J, Soerjomataram I, Dikshit R. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-E386.
4. Hori M, Matsuda T, Shibata A,; Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884-891.
5. Cramp F, Daniel J., Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2008;(2):CD006145.
6. Knight K, Wade S, Balducci L., Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004; 116(suppl 7A):11S-26S.
7. Lyman GH, Poniewieraski MS, Culakova E., Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma. Expert Opin Drug Saf. 2016;15:483-492.
8. Kantarjian H, Giles F, List A. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer. 2007;109:1705-1714.
9. Dehghani M, Haddadi S, Vojdani R., Signs, symptoms and complications of non-Hodgkin’s lymphoma according to grade and stage in South Iran. Asian Pac J Cancer Prev. 2015;16:3551-3557.
10. Grunberg SM, Warr D, Gralla RJ. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—state of the art. Support Care Cancer. 2011;19 (suppl 1):S43-S47.
11. Hjermstand MJ, Fosså SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH., Fatigue in long-term Hodgkin’s disease survivors: a follow-up study. J Clin Oncol. 2005;23:6587-6595.
12. Hall AE, Sanson-Fisher RW, Carey ML. Prevalence and associates of psychological distress in haematological cancer survivors. Support Care Cancer. 2016;24:4413-4422.
13. Bergerot CD, Clark KL, Nonino A, Waliany S, Buso MM, Loscaizo M., Course of distress, anxiety, and depression in hematologic cancer patients: association between gender and grade of neoplasm. Palliat Support Care. 2015;13:115-123.
14. Elter T, Stipanov M, Heuser E. Is physical exercise possible in patients with critical cytopenia undergoing intensive chemotherapy for acute leukaemia or aggressive lymphoma? Int J Hematol. 2009;90:199-204.
15. Morishita S, Kaida K, Tanaka T. Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2012;20:3161-3168.
16. Xiao DY, Luo S, O’Brian K. Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy. Am J Hematol. 2016;91:1002-1007.
17. Kilgour RD, Vigano A, Trutschnigg B. Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer. J Cachexia Sarcopenia Muscle. 2010;1:177-185.
18. Go SI, Park MJ, Song HN. A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma—two are better than one. Oncotarget. 2017;8:47007-47019.
19. Nakano J, Ishii S, Fukushima T, Natsuzako A, Sakamoto J, Okita M., Factors affecting muscle strength in cancer patients receiving chemotherapy. J Nov Physiother Rehabil. 2017;1:56-66.
20. Penninx BW, Pahor M, Cesari M. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52:719-724.
21. Aung KC, Feng L, Yaq KB, Sitoh YY, Leong IY, Ng TP., Serum albumin and hemoglobin are associated with physical function in community-living older persons in Singapore. J Nutr Health Aging. 2011;15:877-882.
22. Thein M, Ershler WB, Artz AS. Diminished quality of life and physical function in community-dwelling elderly with anemia. Medicine (Baltimore). 2009;88:107-114.
23. Stewart R, Hirani V., Relationship between depressive symptoms, anemia, and iron status in older residents from a national survey population. Psychosom Med. 2012;74:208-213.
24. Wu TY, Chie WC, Liu JP, Liaw CK, Netuveli G, Blane D., Association of quality of life with laboratory measurements and lifestyle factors in community dwelling older people in Taiwan. Aging Ment Health. 2015;19:548-559.
25. Mercadante S, Gebbia V, Marrazzo A, Filosto S., Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev. 2000;26:303-311.
26. Kitano T, Tada H, Nishimura T. Prevalence and incidence of anemia in Japanese cancer patients receiving outpatients chemotherapy. Int J Hematol. 2007;86:37-41.
27. Mancuso A, Migliorino M, De Santis S, Saponiero A, De Marinis F., Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol. 2006;17:146-150.
28. Morishita S, Kaida K, Yamauchi S. Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients. Support Care Cancer. 2013;21:2161-2169.
29. Navigante A, Morgado PC, Casbarien O, Delgado NL, Giglio R, Perman M., Relationship between weakness and phase angle in advanced cancer patients with fatigue. Support Care Cancer. 2013;21:1685-1690.
30. Miyatani M, Kanehisa H, Masuo Y, Ito M, Fukunaga T., Validity of estimating limb muscle volume by electrical impedance. J Appl Physiol (1985). 2001;91:386-394.
31. Ishiguro N, Kanehisa H, Miyatani M, Fukunaga T., Applicability of segmental bioelectrical impedance analysis for predicting trunk skeletal muscle volume. J Appl Physiol (1985). 2006;100:572-578.
32. Tanaka NI, Miyatani M, Masuo Y, Fukunaga T, Kanehisa H., Applicability of a segmental bioelectrical impedance analysis for predicting the whole body skeletal muscle volume. J Appl Physiol (1985). 2007;103:1688-1695.
33. Podsiadlo D, Richardson S., The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142-148.
34. Brooks D, Davis AM, Naglie G., Validity of 3 physical performance measures in inpatient geriatric rehabilitation. Arch Phys Med Rehabil. 2006;87:105-110.
35. Oken MM, Creech RH, Tormey DC. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655.
36. Kidd D, Stewart G, Baldry J. The functional independence measure: a comparative validity and reliability study. Disabil Rehabil. 1995;17:10-14.
37. Heinemann AW, Linacre JM, Wright BD, Hamilton BB, Granger C., Relationship between impairment and physical disability as measured by the Functional Independence Measure. Arch Phys Med Rehabil. 1993;74:566-573.
38. Vodermaier A, Millman RD., Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer. 2011;19:1899-1908.
39. Aaronson NK, Ahmedzai S, Bergman B. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
40. Brown DJ, McMillan DC, Milroy R., The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer. 2005;103:377-382.
41. Cesari M, Penninx BW, Lauretani F. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:249-254.
42. Hirani V, Naganathan V, Blyth F. Low hemoglobin concentrations are associated with sarcopenia, physical performance, and disability in older Australian men in cross-sectional and longitudinal analysis: the concord health and ageing in men project. J Gerontol A Biol Sci Med Sci. 2016;71:1667-1675.
43. Hai S, Cao L, Wang H. Association between sarcopenia and nutritional status and physical activity among community-dwelling Chinese adults aged 60 years and older. Geriatr Gerontol Int. 2017;17:1959-1966.
44. Huang RY, Yang KC, Chang HH, Lee LT, Lu CW, Huang KC., The association between total protein and vegetable protein intake and low muscle mass among the community-dwelling elderly population in northern Taiwan. Nutrients. 2016;8:E373.
45. Frontera WR, Hughes VA, Lutz KJ, Evans WJ., A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol (1985). 1991;71:644-650.
46. 2 and force in skeletal muscle. J Appl Physiol (1985). 1993;74:186-191.
47. Yamada E, Takeuchi M, Kurata M, Tsuboi A, Kazumi T, Fukuo K., Low haemoglobin levels contribute to low grip strength independent of low-grade inflammation in Japanese elderly women. Asia Pac J Clin Nutr. 2015;24:444-451.
48. Holzner B, Kemmler G, Greil R. The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol. 2002;13:965-973.
49. Servaes P, Verhagen C, Bleijenberg G., Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38:27-43.
50. Penninx BW, Guralnik JM, Onder G, Ferrucci L, Wallace RB, Pahor M., Anemia and decline in physical performance among older persons. Am J Med. 2003;115:104-110.
51. Dy SM, Lorenz KA, Naeim A, Sanati H, Walling A, Asch SM., Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. J Clin Oncol. 2008;26:3886-3895.
52. Given BA, Given CW, Sikorskii A, Hadar N., Symptom clusters and physical function for patients receiving chemotherapy. Semin Oncol Nurs. 2007;23:121-126.
53. Denny SD, Kuchibhatla MN, Cohen HJ., Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med. 2006;119:327-334.
54. Sabbatini P., The relationship between anemia and quality of life in cancer patients. Oncologist. 2000;5(suppl 2):19-23.
55. Tecchio C, Bonetto C, Bertani M. Predictors of anxiety and depression in hematopoietic stem cell transplant patients during protective isolation. Psychooncology. 2013;22:1790-1797.